导读： 近日，中国科学院沈阳自动化研究所发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理，统计出24项仪器 设备采购意向，预算总额达1.61亿元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，中国科学院沈阳自动化研究所发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理，统计出 2 4项仪器设备采购意向，预算总额达1 . 6 1亿元。 中国科学院沈阳自动化研究所2 0 2 5 年 6 ~ 7 月 仪器设备采购 意向汇总表 | 采购 | | 预算 | 采购 | | --- | --- | --- | --- | | | 需求概况 | | | | 项目 | | 万元 | 时间 | | 多腔 | 主要工作任务是为薄膜生长过程中物理、化学行为及薄膜微观 | | 202 | | 溅射 | | | | | 沉积 | 结构控制等基础问题研究提供实验条件，支撑新型红外光电功 | 450 | 5 年 | | | 能薄膜的生长动力学与制备技术研究。 | | 6 月 | | 设备 | | | | | 基于 | 通过多种传感器记录 ...

导读： 国产替代不仅打破技术垄断，更推动产业从"Me too"向"Me better"甚至"Me different"跃迁，为中国生命科学设备的自主可 控奠定基础。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 随着因美纳被商务部列入"不可靠实体清单"，中国测序仪产业加速迈入"全国产替代"时代。 ▋国产替代：从技术突破到全链自主 华大智造： 依托DNBSEQ技术体系，构建了覆盖低通量（E2 5）到超高通量（T2 0）的全场景产品矩阵。其T2 0平台将 单基因组测序成本降至百美元以下，性能超越国际竞品，成为全球临床检测和大样本研究的标杆方案。 真迈生物： 以SURFSe qQ技术切入高通量赛道，Ge n oLa bMDx与FASTASe q 3 0 0Dx两款设备通过NMPA三类认证，率 先在医疗领域实现商业化替代。 赛陆医疗： 凭借Sa l u sPr o平台的可逆末端终止法技术，实现"芯片-光学-试剂"全产业链自主化，并布局空间组学等前 沿领域，构建"测序+组学"生态闭环。 5月1 4日，赛陆医疗完成复星医药领投的A+轮融资 ，资金用于 ...

Group 1 - The article highlights high-paying job opportunities in the scientific instrument sector, with various positions available across different companies [2][19][14] - Positions include Sales Director, Sales Engineer, Technical Support Engineer, and Application Engineer, with salaries ranging from 8k to 50k per month depending on the role and location [2][6][11] - Companies are seeking candidates with relevant educational backgrounds and experience in fields such as chemistry, materials science, and market sales, emphasizing the need for specialized knowledge in scientific instruments [3][4][9][23] Group 2 - Specific job requirements include a minimum of 3-5 years of experience in sales or technical support within the scientific instrument industry, with some roles requiring advanced degrees [3][4][19][28] - The article mentions the importance of familiarity with specific technologies, such as near-infrared (NIR) applications and chromatography, as a competitive advantage for candidates [4][6][18] - Companies are also looking for candidates with strong communication skills and the ability to travel for business, indicating a demand for versatile professionals in the field [16][21][29]

Core Viewpoint - Domestic substitution not only breaks the technological monopoly but also promotes the transition of the industry from "Me too" to "Me better" and even "Me different," laying the foundation for the autonomy and controllability of China's life science equipment [1] Group 1: User Feedback and Product Selection - The "Domestic Good Instruments" initiative has been ongoing for ten years, emphasizing that "user feedback is the true measure of quality," selecting over 400 high-quality and stable-performing domestic products from thousands of candidates based on long-term user experiences [2] - The initiative has upgraded its approach to better listen to user voices through more in-depth and targeted surveys, helping users find the right products from a vast amount of information [2] Group 2: User Participation and Rewards - Users participating in the survey have the chance to win customized straw glass cups, and those with valid responses will receive a reward of 15 yuan in phone credit [3] - The survey encourages users to engage by filling out questionnaires related to various instruments, with specific models mentioned, such as the JZ-3000T automatic sulfur distillation instrument and the SuPerMax 3100 multifunctional enzyme marker [4][5]

Core Viewpoint - Agilent Technologies reported a revenue of $1.67 billion for Q2 of fiscal year 2025, representing a 6% year-over-year growth, with a net profit of $373 million [1][2]. Revenue Breakdown - The Life Sciences and Diagnostics Group (LDG) generated revenue of $654 million, an 8% increase year-over-year, with a core business growth of 3% and an operating profit margin of 19.7% [4]. - The Agilent CrossLab Group (ACG) achieved revenue of $713 million, a 7% increase year-over-year, with a core business growth of 9% and an operating profit margin of 32.4% [4]. - The Applied Markets Group (AMG) reported revenue of $301 million, a 1% decline year-over-year, with core business remaining flat and an operating profit margin of 19.5% [4]. Regional Performance - Revenue in China grew by 10%, with strong performance in Asia, while the Americas saw low single-digit growth and Europe, the Middle East, and Africa experienced mid-single-digit growth [7]. - The CEO noted that all end markets achieved mid to high single-digit growth, except for a slight decline in the academic and government sectors [7]. Impact of Tariff Events - The CFO stated that the revenue for Q2 was not affected by the April tariff events, with an estimated additional tariff exposure of $5 million for the second half of the fiscal year [8][9]. - The company has implemented supply chain adjustments and cost-saving measures to mitigate the impact of tariffs, expecting to fully offset related costs by fiscal year 2026 [9].

Core Viewpoint - A new wave of standard updates will be implemented in June 2025, with 572 national, industry, and local standards covering various sectors, including agriculture, environmental protection, healthcare, cosmetics, petrochemicals, and textiles, aimed at promoting industrial upgrades and high-quality development [1][2]. Agriculture and Food Sector - 52 new standards will focus on high-standard farmland construction, oil inspection, and feed safety, providing technical support for agricultural production and food safety [4]. - Specific standards include GB/T 33130-2024 for high-standard farmland construction evaluation and GB/T 44965-2024 for the determination of β-carotene acid ethyl ester in feed using high-performance liquid chromatography [4][9]. Environmental Protection Sector - 18 new standards will address hazardous chemical monitoring, water resource management, and waste treatment, promoting environmental safety and resource efficiency [5][11]. Healthcare Sector - 50 new standards will cover medical devices, forensic identification, and drug testing, enhancing the scientific basis for judicial identification [5][11]. - Notable standards include GB/T 19267.13-2025 for the physicochemical testing of trace evidence in forensic science [5][12]. Cosmetics Sector - 23 new standards will focus on ingredient testing and microbial risk assessment, ensuring consumer health protection [5][11]. - Examples include SN/T 2291-2024 for the determination of dextromethorphan hydrobromide in imported cosmetics using liquid chromatography [5][13]. Petrochemical and Textile Sectors - The petrochemical sector will see 47 new standards, while the textile sector will have 40 new standards, focusing on chemical equipment safety, recycled plastics, and harmful substance testing in textiles [5][11]. - Key standards include GB/T 44958-2024 for chemical equipment safety management and GB/T 31126.2-2024 for the determination of perfluoro and polyfluoro compounds in textiles [5][14]. Overall Impact - The implementation of these new standards is expected to enhance the technical level and management capabilities across industries, driving industrial upgrades and sustainable development while providing consumers with safer, higher-quality products and services [6][11].

Core Viewpoint - The article emphasizes the importance of resource management strategies in enhancing organizational resilience and innovation capabilities for small and medium-sized enterprises (SMEs) in the scientific instrument manufacturing sector in dynamic environments [1][5]. Group 1: Research Objectives - The research aims to explore the internal relationship between resource management strategies and organizational resilience and innovation capabilities in SMEs [1]. - The study invites decision-makers from the scientific instrument R&D manufacturing sector to participate in a survey to share their management experiences [1][3]. Group 2: Survey Details - The survey consists of three main parts: company background information (business type, industry category, size), current organizational resilience and innovation status, and the previous year's environmental dynamics and information management conditions [3]. - The estimated completion time for the survey is approximately 10 minutes [3]. Group 3: Privacy and Participation - The data collected from the survey will be used strictly for academic research and will adhere to confidentiality principles, ensuring no sensitive company or personal information is involved [4]. - Participants can engage in the survey by scanning a QR code or clicking a link provided at the end of the article, with the survey open until June 14, 2025 [5].

Core Viewpoint - Bio-Rad is implementing a tariff surcharge due to the impact of the global trade environment on its manufacturing, particularly affecting its life sciences business, while its diagnostics business remains less impacted due to long-term contracts with clients [1][3][4]. Group 1: Company Strategy and Financial Performance - Bio-Rad's CEO and CFO discussed the company's operational strategies and future outlook at the RBC Capital Markets Global Healthcare Conference, emphasizing their commitment to steady growth through operational improvements and strategic acquisitions despite market challenges [2]. - The company is facing revenue pressure estimated at $40 million, primarily due to reduced research spending and challenges in the Chinese market, particularly affecting clients reliant on NIH funding [4]. - Bio-Rad plans to utilize cash and debt flexibly for acquisitions, focusing on products that align with its existing portfolio to enhance market competitiveness [4]. Group 2: Market Conditions and Future Outlook - The company anticipates continued market weakness from Q2 to Q4, affecting academia, biotechnology, and the Chinese market, although consumable usage remains stable, indicating ongoing laboratory activities [5]. - The negative impact of tariffs is estimated to be around 30 basis points, amounting to $30 million to $40 million, which has already been factored into the company's financial guidance [5]. - Based on historical seasonal trends, Bio-Rad expects that the second half of the year will account for 52% of its annual revenue, with a potential performance rebound anticipated in that period [5].

Core Viewpoint - The Ministry of Industry and Information Technology has announced the preliminary list of the first batch of key cultivation pilot platforms, with a total of 242 platforms selected nationwide, covering essential fields for high-quality development in manufacturing [1][3]. Summary by Relevant Sections Pilot Platforms Overview - A total of 242 pilot platforms have been selected, categorized as follows: 79 in raw materials industry, 62 in consumer goods industry, 60 in equipment manufacturing, 21 in information technology, 13 in emerging and future industries, and 7 in common demand fields [3]. Equipment Manufacturing Sector - In the equipment manufacturing sector, 8 instrument and meter pilot platforms have been included, such as: - China Sensor Valley Intelligent Sensor Pilot Platform - Automotive Sensor Pilot Platform - Instrument Functional Materials and Special Sensors Pilot Platform - High-Precision Grating Scale Manufacturing and Application Pilot Platform - Nuclear Power Plant Instrument Pilot Platform - Beijing Jingyi High-End Instruments and Meters Pilot Platform - Guangdong Precision Instruments Advanced Manufacturing Technology Pilot Platform - Mechanical Industry Instrument Comprehensive Research Institute MEMS Sensor Pilot Platform [3][4]. Consumer Goods Industry - In the consumer goods industry, 33 pharmaceutical pilot platforms have been selected, including: - Liaoning Shangyao Northern Pharmaceutical Chemical Pilot Platform - Gene Engineering Drug Clinical Test Sample Preparation Pilot Platform - Innovative Drug Pilot Platform - Various medical device pilot platforms such as the West Lake IBT Biological Intelligence Pilot Platform and Regenerative Medicine Technology and Material Transformation Pilot Platform [5][6]. Medical Devices Sector - The medical devices sector includes 7 pilot platforms, such as: - West Lake IBT Biological Intelligence Pilot Platform - Medical Device Preclinical Animal Testing Safety Efficacy Verification and Inspection Testing Pilot Platform - Blood Dialysis Machine Pilot Platform - Beijing High-End Medical Device CDMO Pilot Platform - Regenerative Medicine Technology and Material Transformation Pilot Platform [7][8].

导读： 近日，中国海洋大学发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理，统计出18项仪器设备采购意向， 预算总额达1.19亿元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日， 中国海洋大学发布 18 项仪器设备采购意向，预算总额达 1. 19 亿 元，涉及水层化海洋模拟实验系统 、 水下 PIV测量系统 、表面波生成与测量一体化系统、海床基在线观测系统 等，预计采购时间为202 5 年 5 月。 中国海洋大学2025年5月 仪器设备采购 意向汇总表 | | | 采 | | --- | --- | --- | | 采购 | | 预算 购 | | | 需求概况 | | | 项目 | | 万元 时 | | 冰洋水 | | 间 | | 文-光 | | 202 | | 学-生 | 本项目建设包括深远海立体观测体系以及学科物理模拟实验平台。包含冰洋水文-光学-生态观测链6台套，自容温盐深观测链3台套，海 | 5 | | 态观测 | 洋大尺度热力动力模拟系统1台套，帮助学生理解海洋大尺度热力和动力过程；提升对北冰洋中小尺度过程 ...